Evidence map›Paper›PMID 36745794›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Brain aerobic glycolysis and resilience in Alzheimer disease.

Manu S Goyal, Tyler Blazey, Nicholas V Metcalf, Mark P McAvoy, Jeremy F Strain, Maryam Rahmani, Tony J Durbin, Chengjie Xiong, Tammie L-S Benzinger, John C Morris and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Sex differences in brain glucose metabolism and Alzheimer's disease risk and progression.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Aging and the Spectral Properties of Brain Hemodynamics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Manu S GoyalMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0003-1970-4270
Tyler BlazeyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Nicholas V MetcalfMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Mark P McAvoyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Jeremy F StrainDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Maryam RahmaniMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Tony J DurbinMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Chengjie XiongKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108.
Tammie L-S BenzingerMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-8114-0552
John C MorrisDepartment of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Marcus E RaichleMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-1847-9588
Andrei G VlassenkoMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.
Washington University in St. Louis · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
Research Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7M
Aerobic Glycolysis in the Development ofAlzheimer's DiseaseR01AG053503 · NIA · WASHINGTON UNIVERSITY · PI RAICHLE, MARCUS E, VLASSENKO, ANDREI G. · 2017 to 2021
$4.1M
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's DiseaseR01AG057536 · NIA · WASHINGTON UNIVERSITY · PI GOYAL, MANU S, VLASSENKO, ANDREI G. · 2017 to 2021
$3.7M
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's DiseaseRF1AG073210 · NIA · WASHINGTON UNIVERSITY · PI GOYAL, MANU S, VLASSENKO, ANDREI G. · 2022 to 2022
$2.3M
PURCHASE OF A SIEMENS NEXT GENERATION PET/CTS10OD025214 · OD · WASHINGTON UNIVERSITY · PI WOODARD, PAMELA K · 2018 to 2018
$2.0M
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's DiseaseR01AG073210 · NIA · WASHINGTON UNIVERSITY · PI Manu S Goyal, ANDREI G. VLASSENKO · 2025 to 2026
$1.4M
NCATS NIH HHS UL1 TR002345NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG053503NIA NIH HHS R01 AG057536NIA NIH HHS R01 AG073210NIA NIH HHS RF1 AG073210NIDDK NIH HHS P30 DK056341NIH HHS S10 OD025214
6 · The paper itself

Abstract

The distribution of brain aerobic glycolysis (AG) in normal young adults correlates spatially with amyloid-beta (Aβ) deposition in individuals with symptomatic and preclinical Alzheimer disease (AD). Brain AG decreases with age, but the functional significance of this decrease with regard to the development of AD symptomatology is poorly understood. Using PET measurements of regional blood flow, oxygen consumption, and glucose utilization-from which we derive AG-we find that cognitive impairment is strongly associated with loss of the typical youthful pattern of AG. In contrast, amyloid positivity without cognitive impairment was associated with preservation of youthful brain AG, which was even higher than that seen in cognitively unimpaired, amyloid negative adults. Similar findings were not seen for blood flow nor oxygen consumption. Finally, in cognitively unimpaired adults, white matter hyperintensity burden was found to be specifically associated with decreased youthful brain AG. Our results suggest that AG may have a role in the resilience and/or response to early stages of amyloid pathology and that age-related white matter disease may impair this process.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloidAmyloid beta-PeptidesAmyloidogenic ProteinsBrainGlycolysisHumansPositron-Emission TomographyYoung AdultAmyloidAmyloid beta-PeptidesAmyloidogenic Proteinsaerobic glycolysisagingAlzheimer's diseaseresiliencewhite matter hyperintensities

Identifiers

PMID36745794
PMCPMC9963219
OpenAlexW4319302837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.